Figure 5. Forearm blood flow (FBF) area under the dose-response curve (AUC) in response to acetylcholine (FBFACh) without (-) or with (+) vitamin C (vitC; left) and oxidative stress-mediated suppression of endothelium-dependent dilation (EDD; right) at week 0 and after 12 weeks of placebo or curcumin supplementation. Data are mean±SE; *P<0.05 vs. corresponding group week FBFACh (left); Group by time P=0.03, *P=0.02 vs. curcumin week 0 (right).